ID   MOC2LN
AC   CVCL_ZD38
DR   GEO; GSM1213097
DR   GEO; GSM1213098
DR   GEO; GSM1213099
DR   Wikidata; Q98127277
RX   PubMed=24668645;
RX   PubMed=25729643;
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gln61His (c.183A>T); Zygosity=Unspecified (from autologous cell line MOC2).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Glu225Ter; Zygosity=Unspecified (from autologous cell line MOC2).
CC   Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
CC   Breed/subspecies: C57BL/6 Cxcr3-/-.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_ZD33 ! MOC2
SX   Female
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
RX   PubMed=24668645; DOI=10.1158/1078-0432.CCR-14-0205;
RA   Onken M.D., Winkler A.E., Kanchi K.-L., Chalivendra V., Law J.H.,
RA   Rickert C.G., Kallogjeri D., Judd N.P., Dunn G.P., Piccirillo J.F.,
RA   Lewis J.S. Jr., Mardis E.R., Uppaluri R.;
RT   "A surprising cross-species conservation in the genomic landscape of
RT   mouse and human oral cancer identifies a transcriptional signature
RT   predicting metastatic disease.";
RL   Clin. Cancer Res. 20:2873-2884(2014).
//
RX   PubMed=25729643; DOI=10.1016/j.gdata.2014.11.006;
RA   Chalivendra V., Kanchi K.-L., Onken M.D., Winkler A.E., Mardis E.R.,
RA   Uppaluri R.;
RT   "Genomic analysis to define molecular basis of aggressiveness in a
RT   mouse model of oral cancer.";
RL   Genomics Data 3:61-62(2015).
//